5 studies found for:    11483335 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Withdrawn Clinical Trial Comparing 3-D RT vs. IMRT in Post- Prostatectomy Prostate Cancer Patients
Condition: Prostate Cancer
Interventions: Radiation: 3-D Conformal Radiation Therapy;   Radiation: Intensity Modulated Radiation Therapy;   Drug: Casodex, Zoladex , Lupron
2 Recruiting Comparative Study of Radiotherapy Treatments to Treat High Risk Prostate Cancer Patients
Condition: Prostate Cancer
Interventions: Radiation: EBRT + HDR brachytherapy boost;   Radiation: Hypofractionated Dose Escalation Radiotherapy;   Drug: Androgen deprivation therapy
3 Unknown  Clinical Trials of Adjuvant Androgen Deprivation in Localized Prostate Cancer
Condition: Prostate Adenocarcinoma
Interventions: Drug: Goserelina 4 months and Bicalutamida;   Drug: Goserelina
4 Active, not recruiting
Has Results
Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: < 15% risk of + LN;   Radiation: > 15% risk of + LN
5 Recruiting Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
Condition: Prostate Cancer
Interventions: Radiation: IMRT to 45 Gy; prostate bed proton boost of 21.6 CGE;   Radiation: Proton (prostate bed) to 70.2 CGE;   Radiation: IMRT to 45 Gy; proton boost to prostate bed to 25.2 CGE;   Radiation: Proton to 66.6 CGE

Indicates status has not been verified in more than two years